Home Visit
Upload
.png)
HE4 With Roma Index Test in Fort
51+ booked in last 3 days
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
The risk of ovarian malignancy algorithm (ROMA) incorporates cancer antigen 125 (CA125), human epididymal protein 4 (HE4), and menopausal status to assign women that present with an adnexal mass into a high-risk or low-risk group for finding an ovarian malignancy.
Human Epithelial 4 (HE4) is a protein that is produced by cells in the ovaries and the lining of the respiratory tract. It is often elevated in women with ovarian cancer and can be used as a biomarker for the disease. CA125 is another protein that is often elevated in women with ovarian cancer, but it can also be elevated in women with other conditions, such as endometriosis, uterine fibroids, and pelvic inflammatory disease.
The ROMA index is a mathematical formula that combines the levels of HE4 and CA125 in the blood to estimate the risk of ovarian cancer. The ROMA index takes into account the age of the woman and whether she has reached menopause.
Associated Tests:
Cancer marker profile-Ovarian-Comprehensive
Ovarian Marker Profile
Written by: Supriya Kulkarni, Lead-Content & Training
HE4 With Roma Index Test Price in Fort
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the HE4 With Roma Index Test with a clear pricing structure
The price of HE4 With Roma Index Test in Fort is ₹ 2,600
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
To assess Risk for finding an ovarian malignancy during surgery in women who present with an adnexal mass.
Test is usful for risk assessment for finding an ovarian malignancy during surgery in women who present with an adnexal mass.
The risk of ovarian malignancy algorithm (ROMA) incorporates cancer antigen 125 (CA125), human epididymal protein 4 (HE4), and menopausal status to assign women that present with an adnexal mass into a high-risk or low-risk group for finding an ovarian malignancy. ROMA is indicated for women who meet the following criteria: older than age 18, presenting with an adnexal mass for which surgery is planned, and who have not yet been referred to an oncologist. ROMA must be interpreted in conjunction with clinical and radiological assessment.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp